Atrás
Rango del Día
$5.33
$5.50
Rango de 52 Semanas
$4.40
$9.77
Volumen
3,818,125
Promedio 50D / 200D
$5.49
/
$7.20
Cierre Anterior
$5.48
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (627 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -4.8 | 0.3 |
| P/B | 0.7 | 2.9 |
| ROE % | -13.9 | 3.7 |
| Net Margin % | -7.9 | 3.8 |
| Rev Growth 5Y % | 5.6 | 10.0 |
| D/E | 0.8 | 0.2 |
Precio Objetivo de Analistas
No hay cobertura de analistas disponible
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$0.14
$0.14 – $0.14
|
2.9 B | 5 |
| FY2029 |
-$0.16
-$0.16 – -$0.15
|
2.7 B | 2 |
| FY2028 |
-$0.72
-$1.31 – $0.36
|
2.6 B | 7 |
Puntos Clave
Revenue grew 5.62% annually over 5 years — modest growth
Generating 285.46M in free cash flow
PEG of 0.08 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 7.16%
Capital efficient — spends only 0.35% of revenue on capex
Crecimiento
Revenue Growth (5Y)
5.62%
Revenue (1Y)-1.54%
Earnings (1Y)N/A
FCF Growth (3Y)21.41%
Calidad
Return on Equity
-13.93%
ROIC-8.13%
Net Margin-7.92%
Op. Margin-10.39%
Seguridad
Debt / Equity
0.75
Current Ratio2.69
Interest Coverage-13.34
Valoración
P/E Ratio
-4.83
P/B Ratio0.70
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -1.54% | Revenue Growth (3Y) | -1.40% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 5.62% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 2.53B | Net Income (TTM) | -200.32M |
| ROE | -13.93% | ROA | -6.46% |
| Gross Margin | 69.50% | Operating Margin | -10.39% |
| Net Margin | -7.92% | Free Cash Flow (TTM) | 285.46M |
| ROIC | -8.13% | FCF Growth (3Y) | 21.41% |
| Safety | |||
| Debt / Equity | 0.75 | Current Ratio | 2.69 |
| Interest Coverage | -13.34 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -4.83 | P/B Ratio | 0.70 |
| P/S Ratio | 0.38 | PEG Ratio | 0.08 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 966.91M | Enterprise Value | 1.23B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2.53B | 2.57B | 2.60B | 2.41B | 2.03B |
| Net Income | -200.32M | -1.00B | -220.37M | -13.66B | -428.79M |
| EPS (Diluted) | -1.14 | -5.87 | -1.34 | -84.60 | -2.73 |
| Gross Profit | 1.76B | 1.82B | 1.84B | 1.66B | 1.38B |
| Operating Income | -262.96M | -1.02B | -248.55M | -13.65B | -265.63M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 3.10B | 3.52B | 4.39B | 4.70B | 17.73B |
| Total Liabilities | 1.72B | 2.03B | 2.07B | 2.39B | 1.69B |
| Shareholders' Equity | 1.39B | 1.49B | 2.33B | 2.31B | 16.05B |
| Total Debt | 1.04B | 1.58B | 1.59B | 1.59B | 1.28B |
| Cash & Equivalents | 781.08M | 1.30B | 1.12B | 918.18M | 893.48M |
| Current Assets | 1.09B | 1.66B | 1.49B | 1.29B | 1.23B |
| Current Liabilities | 404.74M | 941.54M | 420.62M | 399.77M | 331.01M |